Jeffrey Proctor, MD
Urology · Cartersville, GANPI 1902900459
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (38.4%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 44 manufacturers reported payments, led by Valencia Technologies Corporation at 37.4% of the total. Reporting peaked in 2022 at $16,241 and has fallen 52.5% since, to $7,717 in 2025. Among urology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 339 payments — averaging $147.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Valencia Technologies Corporation$19K
- Sumitomo Pharma America, Inc.$13K
- Urovant Sciences Inc$10K
- Medtronic$4K
- Astellas Pharma US Inc$771
- Boston Scientific$349
- plus $3K from 38 others
Across 35 payments — averaging $2189.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$60K
- Urovant Sciences Inc$6K
- Ironwood Pharmaceuticals, Inc$6K
- Sumitomo Pharma America, Inc.$5K
Across 4 payments — averaging $10,004 each. An ownership or investment interest held by the physician or an immediate family member.
- Valencia Technologies Corporation$40K
What the payments were for
- Consulting fees$15,41431%
- Speaking & faculty fees$19,16538%
- Travel & lodging$4,96910%
- Food & beverage$10,16520%
- Education$2380%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GEMTESA$21,674
- eCoin Device Kit$18,540
- INTERSTIM$2,375
- INTERSTIM ICON$290
- GENERAL - THERAPIES$175
- Axonics r-SNM System$170
- KEYTRUDA$125
- WILLIAMS$119
- UroLift System$104
How this compares
$49,951 in reported general payments places this provider in the 95th percentile of 369 urology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErleadaApalutamide | 79 | $1,146,749 |
| OrgovyxRelugolix | 129 | $330,861 |
| XtandiEnzalutamide | 23 | $312,499 |
| NubeqaDarolutamide | 17 | $212,391 |
| GemtesaVibegron | 304 | $188,417 |
| ElmironPentosan Polysulfate Sodium | 93 | $111,182 |
| MyrbetriqMirabegron | 162 | $86,649 |
| Tamsulosin Hcl | 1,391 | $19,472 |
| Heparin SodiumHeparin Sodium,porcine | 18 | $9,856 |
| Testosterone | 56 | $6,530 |
| Trospium Chloride ErTrospium Chloride | 29 | $4,076 |
| Dutasteride | 120 | $3,214 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 183 | $2,885 |
| Solifenacin Succinate | 42 | $2,732 |
| Silodosin | 21 | $1,864 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonErleada | $20 | $1,146,74979 claims |
| Sumitomo Pharma America, Inc.Orgovyx, Gemtesa | $12,973 | $519,278433 claims |
| Astellas Pharma US IncXtandi, Myrbetriq | $771 | $399,148185 claims |
| BayerNubeqa | $236 | $212,39117 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 369 urology providers in Georgia.
Other urology in Cartersville
- Anuj DesaiCartersville$13K
- Vahan KassabianRoswell$1.6M
- Lewis KritemanRoswell$864K
- Daniel CanterDecatur$329K
- Tariq HakkyAtlanta$140K
- Sherita KingAugusta$108K
- Brittani Barrett-HarlowFayetteville$100K
- James BennettAtlanta$93K
- Anthony BarnesAtlanta$89K
- Scott MillerRoswell$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.